| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/02/2001 | CA2339030A1 Analytical elements |
| 08/30/2001 | WO2001063543A2 Method and system for the assembly of a whole genome using a shot-gun data set |
| 08/30/2001 | WO2001063299A1 METHOD FOR CORRELATING BLOOD COAGULATION ACTIVITY WITH MARKERS IN BODY FLUIDS, e.g. URINE |
| 08/30/2001 | WO2001063298A2 Diagnosis of cvd measuring folate and holo-tcii |
| 08/30/2001 | WO2001063297A1 Assay for measuring holo-transcobalamin and folate |
| 08/30/2001 | WO2001063296A2 Method for carrying out the differential diagnostic determination of autoantibodies formed against the tsh receptor in a serum sample or plasma sample of a patient |
| 08/30/2001 | WO2001063295A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 08/30/2001 | WO2001063294A2 Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| 08/30/2001 | WO2001063292A2 Compositions and methods of use of het, a novel modulator of estrogen action |
| 08/30/2001 | WO2001063291A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 08/30/2001 | WO2001063290A1 Bcmp-7 as marker for diagnosis of breast cancer |
| 08/30/2001 | WO2001063289A1 Diagnosis of breast cancer using bcmp-11 as marker |
| 08/30/2001 | WO2001063288A1 Diagnosis of breast cancer using bcmp-81 as marker |
| 08/30/2001 | WO2001063287A1 A method and test kit for avoiding long-term failures in root canal treatments |
| 08/30/2001 | WO2001063286A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 08/30/2001 | WO2001063285A2 Method for detecting helicobacter pylori and heilmanii |
| 08/30/2001 | WO2001063284A2 Internal standards and controls for multiplexed assay |
| 08/30/2001 | WO2001063283A1 Method of measuring physiologically active sample substance by using porous filter |
| 08/30/2001 | WO2001063282A2 Analysis of biological targets using a biochip comprising a fluorescent marker |
| 08/30/2001 | WO2001063281A1 Methods of screening for compounds that modulate blood vessel formation |
| 08/30/2001 | WO2001063280A2 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | WO2001063279A2 Method of identifying toxic agents using differential gene expression |
| 08/30/2001 | WO2001063277A1 Personal computer breath analyzer for health-related behavior modification and method |
| 08/30/2001 | WO2001063272A1 Sensor cartridge, sensor feeder, and measuring instrument |
| 08/30/2001 | WO2001063271A1 Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
| 08/30/2001 | WO2001063267A1 Method of screening compounds for biological activity |
| 08/30/2001 | WO2001063265A1 Measuring method using long life fluorescence of excitation type |
| 08/30/2001 | WO2001063264A1 Optical sensor for measuring oxygen |
| 08/30/2001 | WO2001063245A2 Method and apparatus for high throughput cell - based assays for screening and diagnostics |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001063242A1 Compression tester |
| 08/30/2001 | WO2001063241A2 Microfluidic devices and methods |
| 08/30/2001 | WO2001063217A2 Calibration of array-based sensing system |
| 08/30/2001 | WO2001063101A2 Method for determining motor oil wear |
| 08/30/2001 | WO2001063048A1 System for keeping calender rolls of a paper machine clean |
| 08/30/2001 | WO2001062984A2 Detection of human papilloma viruses |
| 08/30/2001 | WO2001062983A1 Improved methods for generating catalytic proteins |
| 08/30/2001 | WO2001062980A1 Methods for identifying a protease inhibitor |
| 08/30/2001 | WO2001062979A2 Dentification of partial agonists of the a2a adenosine receptor |
| 08/30/2001 | WO2001062978A1 Screening methods for gram-positive enterococcal virulence factors |
| 08/30/2001 | WO2001062975A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 08/30/2001 | WO2001062971A1 Detection of receptors for orphan ligands by retroviral display |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062965A2 Differential expression screening method |
| 08/30/2001 | WO2001062961A1 Ligase/polymerase method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001062960A2 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001062959A2 Endometriosis-related markers and uses thereof |
| 08/30/2001 | WO2001062957A1 Parkin protein as ubiquitin ligase |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062953A2 Electrochemical method for detecting nucleic acids |
| 08/30/2001 | WO2001062943A1 Topoisomerase linker-mediated amplification methods |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062919A1 Modified fluorescent proteins |
| 08/30/2001 | WO2001062915A1 Novel protein and gene encoding the same |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062895A2 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | WO2001062887A1 Chips having elevated sample surfaces |
| 08/30/2001 | WO2001062796A1 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062792A2 Cancer treatment and prognosis involving hes-1 protein |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062787A1 Diagnosis and treatment of bipolar affective disorder |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062725A2 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | WO2001062688A2 Methods of structure-based drug design using ms/nmr |
| 08/30/2001 | WO2001062385A1 Test system based on microcapillaries |
| 08/30/2001 | WO2001062378A2 Microarray fabrication techniques and apparatus |
| 08/30/2001 | WO2001062377A2 Microarray fabrication techniques and apparatus |
| 08/30/2001 | WO2001062306A2 Method and device for controlling the capacity between two electrodes in a gas |
| 08/30/2001 | WO2001062286A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062281A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | WO2001062271A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/30/2001 | WO2001062245A2 Bilirubin or biliverdin degradation fragments |
| 08/30/2001 | WO2001062206A2 N-cadherin modulated migration, invasion, and metastasis |
| 08/30/2001 | WO2001062144A1 Method for transdermal sampling of analytes |
| 08/30/2001 | WO2001033207A8 Microscopic multi-site sensor array with integrated control and analysis circuitry |
| 08/30/2001 | WO2001027621A3 Competitive inhibition elisa for antibody detection |
| 08/30/2001 | WO2001026138A3 Chemical sensor and coating for same |
| 08/30/2001 | WO2001025782A3 Apparatus for measuring conformance of a manufactured food product |
| 08/30/2001 | WO2001025769A3 A substrate and a method for determining and/or monitoring electrophysiological properties of ion channels |
| 08/30/2001 | WO2001016608A3 Apparatus and methods of detecting and controlling twists in multicore cables |
| 08/30/2001 | WO2001016355A3 In vitro test system for gamma-secretase from enriched membranes |
| 08/30/2001 | WO2001013123A3 Method for indirectly determining the blood-clotting status |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001011333A3 Apparatus for real-time measurement of cellular response |
| 08/30/2001 | WO2001011077A3 Methods of diagnosing or treating irritable bowel syndrome and other disorders |
| 08/30/2001 | WO2001010900A3 Globular assembly of amyloid beta protein and uses thereof |
| 08/30/2001 | WO2001010457A3 Pharmaceutical compositions containing tripeptides |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | WO2001008551A3 Luminous glucose monitoring device |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2000073794A3 Method for separating cells using immunorosettes |
| 08/30/2001 | WO2000049410A9 Lcm (laser capture microdissection) for cellular protein analysis |
| 08/30/2001 | WO2000047983A9 Enzyme-linked immuno-magnetic electrochemical biosensor |